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Abstract 
Cancer, as a leading cause of death, has attracted enormous public attention. Reprogramming of cellular energy 
metabolism is deemed to be one of the principal hallmarks of cancer. In this article, we reviewed the mutual relation-
ships among environmental pollution factors, energy metabolic dysfunction, and various cancers. We found that most 
environmental pollution factors could induce cancers mainly by disturbing the energy metabolism. By triggering 
microenvironment alteration, energy metabolic dysfunction can be treated as a factor in carcinogenesis. Thus, we 
put forward that energy metabolism might be as a key point for studying carcinogenesis and tumor development to 
propose new methods for cancer prevention and therapy.
© 2016 Sun et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
Introduction
To date, cancer has become a major public health prob-
lem and has caused global-scale morbidity and mortality 
in modern society. With approximately 14 million new 
cases and 8 million cancer-related deaths in 2012, can-
cer affects populations in all countries and all regions [1]. 
One of the main characteristics of cancer cells is limit-
less replication potential [2], which results in high energy 
requirement. Cancer cells also deregulate energy homeo-
stasis [3]. Thus we cannot ignore the strong connection 
between cancers and energy metabolism, Accordingly, 
seeking new effective therapeutic methods for cancers 
from the perspective of energy metabolic dysfunction as 
a carcinogenesis factor could be possible.
Energy metabolism is one of the most basic characteris-
tics of living organisms. It is associated with the progress 
of metabolic reactions catalyzed by a variety of enzymes. 
The mitochondria are crucial in energy metabolism [4]. 
Most of the cellular energy required for various biological 
functions is provided by the mitochondria through oxi-
dative phosphorylation [5].
Carcinogenesis and energy metabolism can be both 
influenced by the environment. Growing evidence has 
demonstrated that several environmental factors, includ-
ing physical, chemical, and biological environmental 
factors, can disturb cellular energy metabolism. When 
energy metabolic dysfunction occurs, the living cell 
microenvironment and surroundings encounter altera-
tions, which may become conducive to cancer cell pro-
liferation. Leading alterations include acidity [6] and 
interstitial fluid pressure [7] in the microenvironment, 
such alterations can promote risks of carcinogenesis. 
Besides this, hypoxic microenvironment is tightly cor-
related with cancer progression as well [8]. Therefore, 
environmental pollution factors can disturb energy 
homeostasis by triggering microenvironment alteration, 
thereby increasing carcinogenic risks.
In general, we briefly review the relationships among 
energy metabolism, cancers, tumor microenvironment, 
and environmental factors, to attempt to provide new 
perspectives on cancer prevention and treatment.
Review
Energy metabolism disorders in cancer cells
Since Warburg reported that tumor cells in living organ-
isms were associated with abnormal energy utilization 
[9], this phenomenon has continuously attracted research 
attention. Warburg first noted the increased intake of 
glucose and lactate production even in the presence of 
oxygen (aerobic glycolysis) in tumor cells, subsequently 
this phenomenon was named the “Warburg effect”. The 
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Warburg effect has been implicated in cell transforma-
tion, immortalization, and proliferation during tumori-
genesis [10]. At present, most studies have demonstrated 
that energy metabolic dysfunction is one of the major 
features of cancer cells, and it can be driven by multiple 
factors, such as the effect of oncogenes, tumor suppres-
sors, mitochondrial DNA (mtDNA) mutations, and sig-
nal pathways, etc. [11].
Several researches suggested that the altered metabo-
lism with aerobic glycolysis was a feature of cancers 
rather than a cause [12]. In malignant melanoma cells, 
the oncogene BRAF upholds the activity of glycolysis 
and therefore the addiction to glycolysis becomes an 
addiction to BRAF [13]. Furthermore, tumor suppres-
sor p53 has been proven to be related to several energy 
metabolic pathways in cancer cells, such as the tricar-
boxylic acid cycle (TCA cycle), glucose transportation, 
and glycolysis [14]. Growing evidence also indicated that 
mtDNA mutations can increase the reactive oxygen spe-
cies (ROS) production and contribute to tumorigenesis 
through the inhibition of oxidative phosphorylation [15]. 
What’s more, several signal pathways involved in energy 
metabolism in cancer cells show abnormal conditions 
in compared with those in normal cells. The Akt-signal 
pathway mediates multiple cell activities, including cell 
cycle, apoptosis, and glycogen synthesis, which are all 
perturbed in cancer cells. The Akt-signal pathway has 
well been reported to be involved in the regulation of 
intracellular glucose levels favoring hexokinase-mito-
chondria interaction [16, 17]. In particular, PI3  K–Akt–
mTOR signaling, plays an important role in coordinating 
metabolism and promoting cell survival, and the specific 
contributions of Akt hyperactivation to oncogenes have 
been attributed to its fundamental roles in cellular energy 
metabolism of inhibiting apoptosis, increasing cell prolif-
eration, and accelerating oncogenic mutation rates [18].
Aside from the Warburg effect found in cancer cells, 
other abnormal energy metabolic alterations have been 
studied in recent years. The lower ATP generating effi-
ciency of glycolysis in comparison with oxidative phos-
phorylation makes the cancer cells with more glucose 
uptake. Therefore, glucose transporters, which are 
transmembrane proteins in a series, were reported to be 
upregulated in various cancers [19, 20]. Glutaminoly-
sis alteration also occurs in cancer cells [21]. Increasing 
evidence indicated that elevated expression of glutami-
nase enhanced glucose utilization by glutaminolysis in 
prostate cancer [22], and the function of glutaminolysis 
regulation has been discussed by scientists [23]. Several 
reports have asserted that glutamine can be involved in 
multiple energy metabolism-related processes, includ-
ing TCA cycle, gluconeogenic precursor, and lipogenic 
precursor, etc. therefore cancer cells benefit from the 
activation of glutaminolysis, which can also promote the 
pentose phosphate pathway to generate more NADPH. 
Consequently, NADPH can generate reduced glutathione 
(GSH) and decrease the ROS levels to protect the cancer 
cells from excessive oxidative stress [14].
However, a recent scientific report has proposed an 
evolutionary theory that challenges the current under-
standing on cancers, suggesting that cancers are the gen-
erated products of tissue microenvironment alteration 
[24]. Microenvironment alteration can be tightly linked 
with cell energy metabolic dysfunction. Some oncogenic 
mutations gain the upper hand and develop into malig-
nant tumors because the ‘ecosystem’ of a tissue is altered 
in abnormal situations [24]. The said report provides 
new perspectives on the mechanisms of carninogenesis 
and for better therapetic methods for cancers. Given the 
potential relationship between microenvironment and 
cancers, we first summarize the driving environmental 
factors of cancer-linked energy metabolic dysfunction.
Environmental factors contributing to energy metabolism 
dysfunction
Carcinogenic environmental factors are divided into 
three types according to their properties, namely, physi-
cal, chemical, and biological factors. Among the physical 
factors, the most familiar factor is light, especially ultravi-
olet, which promotes risks of cancer generation by induc-
ing gene mutations and disturbing glycolysis [25]. Thus, 
energy metabolism might be altered through the expo-
sure to ultraviolet, and such alteration might be relate to 
cancer generation. Electricity is another physical envi-
ronmental factor linked to energy dysfunction. Ionizing 
radiation can induce endogenously generated ROS. High 
intra-mitochondrial ROS levels damage the mt DNA and 
those mutations can affect the epigenetic control mecha-
nisms of the nuclear DNA by decreasing the activity of 
methyltransferases, thus causing global DNA hypo-
methylation [26]. These changes might increase the risks 
of mutation among energy metabolism-related genes 
and activate the epigenetic regulation of cellular energy 
homeostasis. Our recent study on the effect of electro-
magnetic field on energy metabolism of Caenorhabditis 
elegans has shown an upregulation of the gene expression 
of glycolysis-related enzymes at mRNA levels [27], sug-
gesting that the relationships between this alteration and 
carcinogenic risks should be further investigated.
With regard to the diversified effective mechanisms 
of chemical factors on energy metabolism, one of the 
traditional perspectives implied that cancers are associ-
ated with genetic toxicity. Several chemicals can directly 
or indirectly result in DNA damage (mtDNA or nuclear 
DNA damage) [28, 29]. For example, chemicals may 
bind to DNA to initiate a complexity or disorder in DNA 
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repair; as such, energy-related cell activities, such as cell 
proliferation, cannot be controlled. Moreover, grow-
ing evidence has shown that the mutation of ALDH2 
involved in the oxidative pathway of alcohol metabolism 
can promote hepatocarcinogenesis in murine [30]. Poly-
chlorinated biphenyls, which are potent inducers of toxic 
ROS, have been reported to be capable of inducing DNA 
damage and activating oxidative stress responses [31]. 
Besides the mutational events in chemical carcinogen-
esis, epigenetic alterations also affect the metabolism of 
cells and may be crucial for the development of cancer 
cells [32, 33]. Chemicals can also cause tumors by mecha-
nisms other than directly damaging DNA. Mounting evi-
dence indicates that the disruption of epigenetic balance 
can lead to diseases, including cancers. The contributions 
of various environmental, non-genotoxic carcinogens, 
such as polycyclic aromatic hydrocarbons, benzene, and 
N-nitrosamines, to induce methylome changes associated 
with oncogenic progression have been shown in lung, 
colorectal, and liver oncogenesis, as well as leukemo-
genesis [34, 35]. Metals such as lead, nickel, cobalt, and 
mercury have been reported to disrupt DNA repair, with 
nickel affecting epigenetic histone modification and caus-
ing defective telomere maintenance [36, 37]. A number of 
key metabolites, including SAM, acetyl-CoA, NAD(+), 
and ATP, serve as essential co-factors for many, perhaps 
most, epigenetic enzymes that regulate DNA methyla-
tion, post-translational histone modifications, and nucle-
osome position [38]. Thus, chemical factors inducing 
the abnormal levels of energy metabolites can increase 
the carcinogenic risks. For instance, benzene poisoning 
increased the content level of lipid peroxidation products 
and mitochondrial energetic activities [39], and high per-
oxidation products level was reported to induce epige-
netic alterations in human carcinogenesis [40].
For the biological factors that can affect the mentioned 
energy metabolic levels, we mainly focused on the influ-
ence of microorganisms. Viral, bacterial and fungal infec-
tions can all affect the energy utilization of the body and 
perturb the balance of cell metabolic activities [41–43]. 
The relationship between infection and cancers is a per-
ennial object of study. Among these researches and clini-
cal cases, Rous et  al. first reported the biological and 
chemical pathogenic effects on cancers, and demon-
strated the connection between cancer susceptibility and 
body alteration induced by infection [44]. From the in-
depth study on Helicobacter pylori (HP) infection, several 
findings have suggested that HP infection is linked to the 
pathogenesis of gastric cancer to some extent, and a key 
energy-metabolism related enzyme has been investigated 
simultaneously [45]. HP infection can induce instability 
in mtDNA [46], and mutations in mtDNA can activate 
the mitochondrial oxidative phosphorylation pathway 
[47], further influencing energy generation and utiliza-
tion. Additionally, human papillomavirus (HPV) infec-
tion has been proven correlated with colorectal cancer 
[48], cervical cancer [49], and head and neck cancer [50]. 
Biological environmental factors, including hepatitis B 
and hepatitis C viruses (HBV and HCV), are considered 
among the main causes of hepatocellular carcinoma, 
which should not be ignored as well [51]. Hence, the 
potential of energy metabolic dysfunction to increase 
carcinogenic risks induced by biological factors need to 
be examined further.
Aside from the environmental factors, other aspects, 
particularly individual subjective psychological factors, 
can take participate in the dysfunctional energy metabo-
lism related to cancers [52, 53].
Environmental factors contributing to carcinogenesis 
and cancer progression by microenvironment disruption
In carcinogenesis and cancer development, carcinogenic 
factors and co-carcinogenic factors are highly correlated 
with the human living environment and activities. Com-
plex multi-functional environmental factors can alter the 
concentration and constituents of tissue metabolites. The 
microenvironment of living cells can be a potential driv-
ing factor of carcinogenesis.
Numerous researchers have concluded that tissue 
microenvironment is an important determinant of car-
cinogenesis. One of the contributing factors to cancer 
cell adaptation is a hypoxic environment [54]. Hypoxia 
is associated with increased metastatic potential, devel-
opment of resistance to therapies, and poor prognosis 
[8]. Hypoxic stress can activate the HIF-signal pathway, 
which presents a strong relationship with the energy 
metabolic process, especially in regulating the tri-
osephosphate isomerase expression [55]. Energy meta-
bolic dysfunction can promote the establishment of a 
hypoxic microenvironment, particularly through abnor-
mal mitochondrial aerobic respiration and increased 
rate of glycolysis. An acidic tissue microenvironment 
is also correlated with energy metabolic dysfunction, 
mainly because a high rate of glycolysis generates a large 
amount of lactic acid, which promotes the generation of 
acidic tissue microenvironment [56]. Another contribut-
ing factor is elevated interstitial fluid pressure (IFP). The 
mechanism for elevated IFP was reported to be the dys-
function of the lymphatic system [57]; such dysfunction 
can help cancer cells escape from the attack of functional 
lymphatics and create conducive conditions for various 
metabolites and cell growth factors and cytokines [58].
To emphasize the importance and complexity of the 
microenvironment to cancers, we discuss how environ-
mental factors, such as physical, chemical and biological 
factors, alter the microenvironment. For physical factors, 
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several scientists have reported that radiation can induce 
aerobic glycolysis through ROS generation [59]. Extra-
cellular acidification of the microenvironment has been 
ascribed to lactate secretion from glycolysis [60]. There-
fore, radiation can act on the tumor microenvironment 
by regulating glycolysis. Chemical environmental factors, 
including various natural chemical metabolites and syn-
thetic chemicals, affect cellular microenvironments in 
different ways. One of the approaches disruptive chemi-
cals contribute to the tumor microenvironment is per-
turbing energy homeostasis. For example, chemicals 
affect the gene expression of enzymes involved in energy 
metabolism, thereby promoting the rapid growth and 
proliferation of cells [61]. The persistently high level of 
energy utilization can establish a hypoxia microenviron-
ment for the initiation and development of cancers [62].
Conclusions
Considering the significant role energy metabolism in 
organisms, energy metabolic dysfunction should be 
given substantial attention, particularly on its connec-
tion to human cancers. A sketch of the energy metabolic 
dysfunction promoting the risks of carcinogenesis and 
cancer development is shown in Fig.  1. The alteration 
in energy utilization and generation of cancer cells, that 
is, the occurrence of aerobic glycolysis and disordered 
mitochondrial oxidative phosphorylation can provide 
































Fig. 1 Schematic of energy metabolism dysfunction promoting carcinogenic risks and cancer development. Different types of environmental 
factors (physical, chemical and biological factors) could act on cancer cells and the tumor microenvironment. Cancer cells usually show aerobic 
glycolysis and abnormal signal pathway regulations. Pentose phosphate pathway can be upregulated to increasing the amount of NADPH and 
ribose-5-phoshate, which are used for energy generation and DNA replication, as well as counteracting proportion of ROS for protecting cancer 
cells from oxidative stress. The inhibition of oxidative phosphorylation at the same time can result in the accumulation of lactate and the acid micro-
environment. Moreover, several signal pathways, such as the Akt-mTOR signal pathway and the HIF signal pathway, are involved in the dysfunction 
of energy metabolism and can co-active a hypoxic tumor microenvironment
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development. Other alterations, namely glutaminolysis, 
ROS level, and signal pathways, can be closely associated 
with energy metabolism. The tumor microenvironment 
which usually shows the features of hypoxia, accumula-
tion of acidic metabolites and interstitial fluid pressure, 
provides a suitable microenvironment for uncontrollable 
cell proliferation and increases the risks of cancer gen-
eration. Energy metabolism alteration can be related to 
environmental factors, which we classified into three cat-
egories, namely physical, chemical, and biological factors. 
The possible relationships among environmental factors, 
cancers (mainly carcinogenesis), and energy metabolism 
are presented in Fig. 2. In the figure, we emphasize that 
energy metabolic dysfunction can directly or indirectly 
contribute to cancers as a carcinogenic factor, probably 
by affecting the microenvironment. Furthermore, other 
factors, such as individual subjective factors, and psycho-
logical factors, can be involved in energy metabolic dys-
function. We propose that owing to the important role 
of energy metabolism dysfunction in promoting cancer 
risks, energy metabolic dysfunction as a carcinogenic fac-
tor cannot be ignored.
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